Saltar al contenido
Merck

793558

Sigma-Aldrich

Sodium iodide

anhydrous, free-flowing, Redi-Dri, ReagentPlus®, ≥99%

Iniciar sesiónpara Ver la Fijación de precios por contrato y de la organización


About This Item

Fórmula lineal:
NaI
Número de CAS:
Peso molecular:
149.89
EC Number:
MDL number:
UNSPSC Code:
12352302
PubChem Substance ID:
NACRES:
NA.21

grade

anhydrous

Quality Level

vapor density

>1 (vs air)

product line

ReagentPlus®
Redi-Dri

assay

≥99%

form

powder

quality

free-flowing

impurities

≤1.0% water

pH

6-9 (20 °C, 50 g/L)

mp

661 °C (lit.)

SMILES string

[Na+].[I-]

InChI

1S/HI.Na/h1H;/q;+1/p-1

InChI key

FVAUCKIRQBBSSJ-UHFFFAOYSA-M

¿Está buscando productos similares? Visita Guía de comparación de productos

General description

Sodium iodide is an inorganic sodium salt. It is used as an iodinating agent in organic synthesis to prepare various iodine-containing compounds. It is used in the conversion of alkyl halides and sulfonates into alkyl iodides and aryl iodides via nucleophilic displacement reactions. Additionally, sodium iodide is also used in combination with oxidizing agents for the iodination of organoboranes, phenols, and aromatic compounds.

Application

Sodium iodide can be used as an iodine precursor salt to synthesize semi-organic nonlinear optical single crystal of bis thiourea sodium iodide (BTSI) via slow evaporation solvent technique.

Legal Information

ReagentPlus is a registered trademark of Merck KGaA, Darmstadt, Germany
Redi-Dri is a trademark of Sigma-Aldrich Co. LLC

pictograms

Exclamation mark

signalword

Warning

hcodes

Hazard Classifications

Eye Irrit. 2

Storage Class

13 - Non Combustible Solids

wgk_germany

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable


Elija entre una de las versiones más recientes:

Certificados de análisis (COA)

Lot/Batch Number

¿No ve la versión correcta?

Si necesita una versión concreta, puede buscar un certificado específico por el número de lote.

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos

Los clientes también vieron

Brian A Rabe et al.
Proceedings of the National Academy of Sciences of the United States of America, 117(39), 24450-24458 (2020-09-10)
The current severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has had an enormous impact on society worldwide, threatening the lives and livelihoods of many. The effects will continue to grow and worsen if economies begin to open without the
P E N Braad et al.
Physics in medicine and biology, 60(13), 5297-5312 (2015-06-26)
Peri-therapeutic (124)I-PET/CT is of interest as guidance for radioiodine therapy. Unfortunately, image quality is complicated by dead time effects and increased random coincidence rates from high (131)I-activities. A series of phantom experiments with clinically relevant (124)I/(131)I-activities were performed on a
Kohei Sano et al.
Biochemical and biophysical research communications, 464(3), 820-825 (2015-07-15)
Photoacoustic (PA) imaging is an attractive imaging modality for sensitive and depth imaging of biomolecules with high resolution in vivo. The aim of this study was to evaluate the effectiveness of an anti-epidermal growth factor receptor (EGFR) monoclonal antibody (panitumumab; Pan)
Anke de Vries et al.
Investigative radiology, 50(4), 297-304 (2015-01-01)
The objective of this study was to investigate the feasibility and the accuracy of spectral computed tomography (spectral CT) to determine the tissue concentrations and localization of high-attenuation, iodine-based contrast agents in mice. Iodine tissue concentrations determined with spectral CT
Zhibo Liu et al.
Molecular pharmaceutics, 12(3), 974-982 (2015-01-30)
Bradykinin B1 receptor (B1R) is involved in pain and inflammation pathways and is upregulated in inflamed tissues and cancer. Due to its minimal expression in healthy tissues, B1R is an attractive target for the development of therapeutic agents to treat

Artículos

Redi-Dri™ prevents hygroscopic powders, such as inorganic salts, from absorbing moisture and forming clumps, leaving the salts free-flowing every time.

Redi-Dri™ prevents hygroscopic powders, such as inorganic salts, from absorbing moisture and forming clumps, leaving the salts free-flowing every time.

Redi-Dri™ prevents hygroscopic powders, such as inorganic salts, from absorbing moisture and forming clumps, leaving the salts free-flowing every time.

Redi-Dri™ prevents hygroscopic powders, such as inorganic salts, from absorbing moisture and forming clumps, leaving the salts free-flowing every time.

Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.

Póngase en contacto con el Servicio técnico